Haelan 951 for Menopause Symptoms in Peri- and Postmenopausal Women

This proof-of-concept, open-label, single-arm study is designed to evaluate the effects of daily consumption of Haelan 951, a fermented soy conventional food product, on self-reported menopausal vasomotor symptoms, sleep quality, and health-related quality of life in peri- and postmenopausal women. The study will collect descriptive data on participant-reported outcomes over the study period to assess the feasibility and potential effects of Haelan 951 in supporting menopausal wellness. The study is not intended to evaluate the treatment, prevention, or cure of any disease.

NCT Number	NCT07751029
Lead Sponsor	Spectrum Clinical Research, LLC Collaborators: Haelan Products, Inc., NexTrial AI Inc
Conditions	Menopause, Menopause Hot Flashes, Menopause Related Conditions
Enrollment	25 participants
Start Date	2026-08
Primary Completion	2026-09 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-10